INDENTURE dated as of August 26, 2008 by and between LEDGEMONT ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, as initial trustee of the Notes described hereinIndenture • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
This INDENTURE, dated as of August 26, 2008, is by and between LEDGEMONT ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee of the Notes described herein.
PLEDGE AND SECURITY AGREEMENT MADE BY EACH UNDERSIGNED EQUITYHOLDER TO U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE DATED AS OF AUGUST 26, 2008Pledge and Security Agreement • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
This PLEDGE AND SECURITY AGREEMENT, dated as of August 26, 2008, is made by each undersigned Equityholder in favor of U.S. Bank National Association, a national banking association, as the Trustee under the Indenture, as grantee hereunder.
LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT by and between INDEVUS PHARMACEUTICALS, INC. and ORION CORPORATIONLicense, Supply and Distribution Agreement • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
WHEREAS, Orion is engaged, directly and through its Affiliates and Marketing Distributors (as defined herein) in the business of developing, producing and selling pharmaceutical products;
PURCHASE AND SALE AGREEMENT dated as of August 26, 2008 between INDEVUS PHARMACEUTICALS, INC. and LEDGEMONT ROYALTY SUB LLCPurchase and Sale Agreement • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This PURCHASE AND SALE AGREEMENT (this “Agreement”) dated as of August 26, 2008 is between Indevus Pharmaceuticals, Inc., a Delaware corporation (“Seller”), and Ledgemont Royalty Sub LLC, a Delaware limited liability company (“Purchaser”).
DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT by and between INDEVUS PHARMACEUTICALS, INC. and TEVA PHARMACEUTICAL INDUSTRIES LTD.Development, License and Commercialization Agreement • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is made as of September 25, 2008 (“Agreement Date”), by and between INDEVUS PHARMACEUTICALS, INC., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 33 Hayden Avenue, Lexington, MA 02421, United States (“Indevus”) and TEVA PHARMACEUTICAL INDUSTRIES LTD., a limited liability company existing under the laws of Israel and having its principal office at Petah Tiqva 49131, Israel (“Teva”).
NOTE PURCHASE AGREEMENT dated August 26, 2008 among LEDGEMONT ROYALTY SUB LLC, INDEVUS PHARMACEUTICALS, INC. and THE PURCHASER NAMED HEREINNote Purchase Agreement • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
Ledgemont Royalty Sub LLC, a Delaware limited liability company, and Indevus Pharmaceuticals, Inc., a Delaware corporation, hereby covenant and agree with you as follows:
